Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Angst

Showing results (231-240 of 273) with videos related to

Pageof 28
Sort By:
Social Psychiatry and Psychiatric Epidemiology|July 4, 2012
The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depressionB Silverstein, T Edwards, A Gamma, et al.
Psychological Medicine|April 19, 2003
Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adultsL Pezawas, H U Wittchen, H Pfister, et al.
Advances in Biochemical Psychopharmacology|January 1, 1974
The effect of L-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro-4-4602) in depressive patientsN Matussek, J Angst, O Benkert, et al.
Journal of Affective Disorders|June 5, 2003
Cyclothymic OCD: a distinct form?E G Hantouche, J Angst, C Demonfaucon, et al.
International Pharmacopsychiatry|January 1, 1977
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277)B Woggon, A Franke, H Hucker, et al.
Acta Psychiatrica Scandinavica|February 6, 2013
The bipolar-borderline personality disorders connection in major depressive patientsG Perugi, J Angst, J-M Azorin, et al.
Journal of Affective Disorders|December 21, 2000
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disordersH S Akiskal, M L Bourgeois, J Angst, et al.
Lancet (London, England)|March 19, 1983
Successful treatment of depression with tetrahydrobiopterinH C Curtius, A Niederwieser, R A Levine, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosisF X Vollenweider, K L Leenders, C Scharfetter, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 23, 2018
Bipolar spectrum in major depressive disordersJ Angst, K R Merikangas, L Cui, et al.
Pageof 28

Showing results (231-240 of 273) with videos related to

Sort By:
Pageof 28
Social Psychiatry and Psychiatric Epidemiology|July 4, 2012
The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depressionB Silverstein, T Edwards, A Gamma, et al.
Psychological Medicine|April 19, 2003
Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adultsL Pezawas, H U Wittchen, H Pfister, et al.
Advances in Biochemical Psychopharmacology|January 1, 1974
The effect of L-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro-4-4602) in depressive patientsN Matussek, J Angst, O Benkert, et al.
Journal of Affective Disorders|June 5, 2003
Cyclothymic OCD: a distinct form?E G Hantouche, J Angst, C Demonfaucon, et al.
International Pharmacopsychiatry|January 1, 1977
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277)B Woggon, A Franke, H Hucker, et al.
Acta Psychiatrica Scandinavica|February 6, 2013
The bipolar-borderline personality disorders connection in major depressive patientsG Perugi, J Angst, J-M Azorin, et al.
Journal of Affective Disorders|December 21, 2000
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disordersH S Akiskal, M L Bourgeois, J Angst, et al.
Lancet (London, England)|March 19, 1983
Successful treatment of depression with tetrahydrobiopterinH C Curtius, A Niederwieser, R A Levine, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosisF X Vollenweider, K L Leenders, C Scharfetter, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 23, 2018
Bipolar spectrum in major depressive disordersJ Angst, K R Merikangas, L Cui, et al.
Pageof 28